Key Highlights
- The Pediatric Cancer Research Foundation (PCRF) announces leadership team expansion with Jeri Wilson transitioning to VP of Development and Danielle Fragalla stepping in as CEO.
- Under Wilson’s leadership, PCRF has grown significantly, funding research at top institutions and granting $46 million to pediatric cancer research.
- Fragalla brings extensive experience in nonprofit management and development, aiming to further PCRF’s mission and strategic growth in pediatric cancer care.
Source: Business Wire
Notable Quotes
- “Jeri has been a transformational leader… Danielle comes to us with a passion for our cause and a wealth of experience.” – Steve Giusto, Board President at PCRF
- “Danielle is the right person to helm this organization now… I am excited by the potential of what we can accomplish together.” – Jeri Wilson, Vice President of Development, Principal Gifts at PCRF
- “…nothing should prevent children and their families from experiencing the joys of childhood. I look forward to partnering with the board, team, and community…” – Danielle Fragalla, Chief Executive Officer at PCRF
SoHC's Take
The Pediatric Cancer Research Foundation’s strategic leadership changes mark a pivotal moment in its mission to combat pediatric cancer. Jeri Wilson’s transition to VP of Development, Principal Gifts, leverages her profound impact and success over the past 12 years, ensuring her expertise continues to support PCRF’s vital work. Danielle Fragalla’s appointment as CEO is a testament to her significant contributions and leadership in the nonprofit sector, promising a new era of growth and innovation for PCRF.
With a clear vision and committed leadership, the Foundation is poised to enhance its contribution to pediatric cancer research, aspiring to a future where children facing cancer can overcome their illness and realize their full potential. This leadership expansion reflects PCRF’s dedication to accelerating research breakthroughs and its unwavering commitment to children and families affected by pediatric cancer.
